慢性阻塞性肺疾病急性加重评估及稳定期用药选择:慢性阻塞性肺疾病全球倡议2015解读被引量：3

导出

摘要 2015版慢性阻塞性肺疾病（chronic obstructive pulmonary disease,COPD）全球倡议（Global Initiative for Chronic Obstructive Lung Disease,GOLD）[1]根据2014年1月至12月期间新检索的312篇文献中31篇颇具影响力的研究成果所提供的循证医学依据,在2014版的基础上进行了修改,特别是对于COPD急性加重（acuteexacerbationofCOPD，AE-COPD）的评估、预后影响因素及药物治疗预防作用的最新进展作了详尽的阐述。

作者李庆云过依

机构地区上海交通大学医学院附属瑞金医院呼吸科

出处《诊断学理论与实践》 2015年第3期215-218,共4页 Journal of Diagnostics Concepts & Practice

关键词慢性阻塞性肺疾病评估全球倡仪

分类号 R735 [医药卫生—肿瘤]

引文网络
相关文献

参考文献24

1Global strategy for the diagnosis, management and pre- vention of chronic obstructive pulmonary disease (upda- ted 2015)[EB/OL]. 2015-Ol[2015-06-04].http://www.gold- copd.org/guidelines-globalstrategy-for-diagnosis-manage- ment.html.
2陈建,王广发.慢性阻塞性肺疾病全球倡议2011修订版解读[J].中国医学前沿杂志（电子版）,2012,4(1):42-44. 被引量：65
3Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma[J]. Proc Am Thorac Soc,2004,1 (2):136- 142.
4Kew KM, Mavergames C, Wahers JA. Long-acting beta2- agonists for chronic obstructive pulmonary disease [J]. Cochrane Database Syst Rev,2013,10:CD010177.
5Zheng JP, Wen FQ, Bai CX, et al. Twice daily N-acetyl- cysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double- blind placebo-controlled trial[J]. Lancet Respir Med,2014, 2(3):187-194.
6Poole P, Black PN, Cares CJ. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary di- sease[J]. Cochrane Database Syst Rev,2012,8:CD001287.
7Tse HN, Raiteri L, Wong KY, et al. High-dose N-acetyl- cysteine in stable COPD: the 1-year, double-blind, ran- domized, placebo-controlled HIACE study[J]. Chest,2013, 144(1):106-118.
8Lundback BLM, Andersson S. Possible effect of acetyl- cysteine on lung function[J]. Eur Respir J,1992,5 (Suppl 15):895.
9Decramer M, Rutten-van Mt~lken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial[J]. Lancet,2005,365(9470):1552- 1560.
10Marjanovi6 N, Bosnar M, Michielin F, et al. Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro[J]. Pharmacol Res,2011,63(5):389-397.

二级参考文献1

1Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/guidelines-pocket-guide-to-copd-diagnosis.html . 2011